Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_assertion wasGeneratedBy ECO_0000203 NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_assertion wasDerivedFrom befree-20140225 NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_assertion SIO_000772 17214581 NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_assertion evidence source_evidence_literature NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_assertion description "[Results from phase-II clinical trials with a BLyS antagonist in human SLE and RA have shown the antagonist to have biological and clinical activity along with a favorable safety profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP384215.RAQESQvdlrlaZhRLmsUMTM8Iwb5F05HcJubUdIAzpn3LA130_provenance.